Ophthalmic formulations including selective alpha 1 antagonists

作者: Gerald Horn

DOI:

关键词:

摘要: Ophthalmic formulations are provided. The ophthalmic include one or more active agents that act to optimize pupil light reflex while minimizing, effectively eliminating, any undesired eye redness in response application thereof. include, for example, alpha 1 antagonists, such as 1a selective antagonists.

参考文章(58)
Larry C. Goddard, Eye dropper attachment ,(1990)
Delford O. Dougherty, Eye dropper with light source ,(1983)
David L. Edwards, Target ring for an eye dropper bottle ,(1981)
John D. Valberg, Illuminated eye dropper device ,(1995)
J. Marshall, D.P.S. O'Brart, C.P. Lohmann, F.W. Fitzke, S.E. Smith, M.G. Kerr-Muir, Night vision after excimer laser photorefractive keratectomy: haze and halos European Journal of Ophthalmology. ,vol. 4, pp. 43- 51 ,(1994) , 10.1177/112067219400400108
J D Levine, D L Jewett, F Perry, P H Heller, Autonomic components of the human pupillary light reflex. Investigative Ophthalmology & Visual Science. ,vol. 31, pp. 156- 162 ,(1990)
C G Connor, W W Tirey, J B Campbell, The clinical efficacy of Rev-Eyes in reversing the effects of pupillary dilation. Journal of the American Optometric Association. ,vol. 64, pp. 634- 636 ,(1993)